GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aeolus Pharmaceuticals Inc. (AOLS.OB) [hlAlert]

Rating:
Buy AOLS.OB

Aeolus Pharma (AOLS.OB) rated Buy with price target $1.25 by Ladenburg Thalmann

Posted on: Thursday,  Aug 25, 2011  8:25 AM ET by Ladenburg Thalmann

Aeolus Pharma (AOLS.OB) rated
Buy with price target $1.25 by Ladenburg Thalmann.

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of a class of catalytic antioxidant compounds. It offers catalytic antioxidant compounds as a medical countermeasure against biological, chemical, and radiological weapons, as well as for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. The company develops AEOL 10150, which completed two Phase I clinical trials for various indications, such as medical countermeasure against the effects of acute radiation syndrome in the lungs and gastro-intestinal tract; and as a countermeasure for exposure to chemical vesicants, including chlorine gas and sulfur mustard gas. It also has two programs for the development of AEOL 11207, a drug candidate for the potential treatment of epilepsy and Parkinson?s disease. The company was founded in 1994 and is based in Mission Viejo, California.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/25/2011 8:25 AM Buy
None
1.25
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy